NCT00406965View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

September 30, 2007

Conditions
Allergic Asthma
Interventions
DRUG

HAE1 (PRO98498)

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY